Mohamed Nasr

1.2k total citations
38 papers, 917 citations indexed

About

Mohamed Nasr is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Mohamed Nasr has authored 38 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 12 papers in Molecular Biology and 8 papers in Biomaterials. Recurrent topics in Mohamed Nasr's work include Drug Solubulity and Delivery Systems (9 papers), Advanced Drug Delivery Systems (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Mohamed Nasr is often cited by papers focused on Drug Solubulity and Delivery Systems (9 papers), Advanced Drug Delivery Systems (9 papers) and Nanoparticle-Based Drug Delivery (6 papers). Mohamed Nasr collaborates with scholars based in Egypt, Saudi Arabia and Iraq. Mohamed Nasr's co-authors include Mohamed K. Ghorab, Fahima Hashem, Ahmed Z. Abdelazem, Aliaa Ismail, Sameh Saber, Rania S. Abdel-Rashid, Dalia S. Shaker, Hassan Younes, Ebtessam A. Essa and Sanaa A. El‐Gizawy and has published in prestigious journals such as Materials, International Journal of Nanomedicine and Biomedicine & Pharmacotherapy.

In The Last Decade

Mohamed Nasr

36 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Nasr Egypt 17 446 332 198 115 83 38 917
Abdullah H. Alomrani Saudi Arabia 16 414 0.9× 240 0.7× 265 1.3× 64 0.6× 100 1.2× 32 785
Mohamed M. Badran Saudi Arabia 17 366 0.8× 189 0.6× 171 0.9× 74 0.6× 84 1.0× 30 738
Kalvatala Sudhakar India 16 305 0.7× 433 1.3× 176 0.9× 113 1.0× 125 1.5× 38 1.2k
Marwa A. Sallam Egypt 19 283 0.6× 350 1.1× 251 1.3× 70 0.6× 186 2.2× 34 1.0k
Sanaa A. El‐Gizawy Egypt 22 539 1.2× 286 0.9× 285 1.4× 136 1.2× 133 1.6× 50 1.2k
Asim ur Rehman Pakistan 19 492 1.1× 164 0.5× 163 0.8× 93 0.8× 86 1.0× 45 981
Amany O. Kamel Egypt 24 728 1.6× 473 1.4× 283 1.4× 131 1.1× 128 1.5× 36 1.4k
Vaishali Londhe India 20 516 1.2× 216 0.7× 128 0.6× 91 0.8× 135 1.6× 66 1.1k
Harshad Harde India 16 653 1.5× 336 1.0× 184 0.9× 56 0.5× 53 0.6× 19 984
Akhlesh Kumar Jain India 13 438 1.0× 450 1.4× 263 1.3× 158 1.4× 126 1.5× 43 1.2k

Countries citing papers authored by Mohamed Nasr

Since Specialization
Citations

This map shows the geographic impact of Mohamed Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Nasr more than expected).

Fields of papers citing papers by Mohamed Nasr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Nasr. The network helps show where Mohamed Nasr may publish in the future.

Co-authorship network of co-authors of Mohamed Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Nasr. A scholar is included among the top collaborators of Mohamed Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Nasr. Mohamed Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasr, Mohamed, et al.. (2024). Localized delivery of Roxadustat via cubosomes-based thermosensitive in-situ hydrogel enhances diabetic wound healing by stabilizing HIF-1α in rats. Journal of Drug Delivery Science and Technology. 100. 106127–106127. 8 indexed citations
2.
Saber, Sameh, et al.. (2024). Silk fibroin/gelatin electrospun nanofibrous dressing loaded with roxadustat accelerates wound healing in diabetic rats via HIF-1α stabilization. Journal of Drug Delivery Science and Technology. 103. 106439–106439. 1 indexed citations
3.
Nasr, Mohamed, et al.. (2024). Optimization of nano-structured lipid carriers for enhanced salbutamol delivery via buccal mucoadhesive film. Journal of Drug Delivery Science and Technology. 104. 106468–106468. 2 indexed citations
4.
Nasr, Mohamed, et al.. (2023). Folic acid grafted mixed polymeric micelles as a targeted delivery strategy for tamoxifen citrate in treatment of breast cancer. Drug Delivery and Translational Research. 14(4). 945–958. 18 indexed citations
5.
6.
Nasr, Mohamed, et al.. (2021). Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles. Pharmaceuticals. 14(8). 786–786. 28 indexed citations
7.
Alfaifi, Mohammad Y., et al.. (2020). Use of Secondary Metabolites Derived from Aspergillus Species as Anticancer Agents and Related Histological and Genetic Alterations: In Vitro Study. Journal of Cytology & Histology. 11(1). 1–7. 1 indexed citations
8.
Nasr, Mohamed, et al.. (2020). In Vitro Cytotoxicity and Cellular Uptake of Tamoxifen Citrate-Loaded Polymeric Micelles. AAPS PharmSciTech. 21(8). 306–306. 2 indexed citations
9.
Nasr, Mohamed, Hassan Younes, & Rania S. Abdel-Rashid. (2020). Formulation and evaluation of cubosomes containing colchicine for transdermal delivery. Drug Delivery and Translational Research. 10(5). 1302–1313. 69 indexed citations
10.
Nasr, Mohamed, et al.. (2020). In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis. Drug Delivery and Translational Research. 10(6). 1841–1852. 42 indexed citations
11.
Hashem, Fahima, et al.. (2019). <p>In vitro cytotoxicity and transfection efficiency of pDNA encoded p53 gene-loaded chitosan-sodium deoxycholate nanoparticles</p>. International Journal of Nanomedicine. Volume 14. 4123–4131. 12 indexed citations
12.
Hashem, Fahima, et al.. (2015). Formulation and In Vitro and In Vivo Evaluation of Lipid-Based Terbutaline Sulphate Bi-layer Tablets for Once-Daily Administration. AAPS PharmSciTech. 17(3). 727–734. 9 indexed citations
13.
Nasr, Mohamed, Mohamed K. Ghorab, & Ahmed Z. Abdelazem. (2014). In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharmaceutica Sinica B. 5(1). 79–88. 178 indexed citations
14.
Hashem, Fahima, et al.. (2013). In vitrocytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate. Pharmaceutical Development and Technology. 19(7). 824–832. 30 indexed citations
15.
Nasr, Mohamed. (2013). Influence of Microcrystal Formulation on In Vivo Absorption of Celecoxib in Rats. AAPS PharmSciTech. 14(2). 719–726. 21 indexed citations
16.
Nasr, Mohamed, et al.. (2012). Development and characterization of solid lipid dispersion as delivery system for hydrophilic antihypertensive drug atenolol. International Journal of Phytomedicine. 4(2). 219–228. 6 indexed citations
17.
Hashem, Fahima, et al.. (2012). In Vitro and In Vivo Evaluation of Oxatomide β-Cyclodextrin Inclusion Complex. PubMed. 2013. 1–9. 2 indexed citations
18.
Hashem, Fahima, Dalia S. Shaker, Mohamed K. Ghorab, Mohamed Nasr, & Aliaa Ismail. (2011). Formulation, Characterization, and Clinical Evaluation of Microemulsion Containing Clotrimazole for Topical Delivery. AAPS PharmSciTech. 12(3). 879–886. 104 indexed citations
20.
Nasr, Mohamed, et al.. (2010). Preparation and characterization of niosomes containing ribavirin for liver targeting. Drug Delivery. 17(5). 282–287. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026